EMERGENT BIOSOLUTIONS INC. EBS Balance Sheet

Emergent biosolutions inc. (EBS)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Dec'10
ASSETS
Current assets:
Cash and cash equivalents
181,500	167,800	139,200	177,400	137,200	112,200	339,358	190,237	163,606	178,300	340,991	315,627	270,170	271,513	298,932	333,395	341,016	308,304	308,718	214,841	216,515	280,499	242,249	168,130	160,215	179,338	172,561	156,243	130,238	141,666	197,901	161,843	150,425	143,901	125,346	122,094	169,019
Restricted cash
200	200	200	200	200	200	1,043	1,043	1,043	1,000	1,043	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	220	217	217	217
Investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	1,966	3,499	5,048	2,029
Accounts receivable, net
162,500	270,700	281,200	218,100	121,500	262,500	76,955	189,489	122,090	143,700	129,357	102,511	128,082	138,478	69,633	66,749	69,560	113,906	57,037	99,718	64,059	58,834	44,111	78,270	62,938	60,587	30,093	54,369	62,964	96,043	17,085	46,815	43,652	74,153	48,994	47,263	39,326
Inventories
248,100	222,500	230,200	232,000	211,000	205,800	125,745	139,373	155,196	142,800	68,889	70,529	70,732	74,002	81,160	96,674	88,200	60,887	80,070	84,708	82,134	65,674	62,533	66,030	71,268	14,643	16,325	18,582	22,148	15,161	18,245	16,008	17,319	14,661	17,979	17,262	12,722
Deferred tax assets, current portion, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	1,483	1,483	1,656	1,710	-	-	-	0	1,264	1,264	1,264	1,264	327	638	441	1,735	7,209	7,082	2,638
Income tax receivable, net
10,200	4,600	-	-	-	8,600	0	0	7,044	2,400	0	6,119	6,771	9,996	11,831	9,184	3,771	6,573	3,433	13,142	17,023	1,357	8,262	16,674	17,800	5,651	588	6,502	10,762	0	9,618	10,422	19,798	9,506	24,488	17,136	8,728
Prepaid expenses and other current assets
24,100	20,400	49,200	65,000	58,600	31,500	20,047	21,166	27,670	17,200	15,754	14,955	13,411	16,229	18,439	22,045	25,613	18,458	22,749	21,596	24,424	24,101	26,477	16,345	14,982	12,896	13,184	11,199	9,703	9,213	9,759	7,489	7,907	8,276	9,033	7,742	8,814
Current assets of discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	29,282	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total current assets
626,600	686,200	700,000	692,700	528,500	620,800	563,148	541,308	476,649	485,400	556,034	509,741	489,166	510,218	479,995	528,047	528,160	537,410	473,490	435,488	405,811	432,175	383,632	345,449	327,203	273,115	234,015	248,159	237,079	263,347	252,935	243,215	239,542	254,418	236,765	223,844	243,493
Property, plant and equipment, net
549,200	542,300	529,100	520,500	513,400	510,200	435,075	419,157	411,269	407,200	386,457	380,240	381,102	376,448	362,544	359,034	342,083	327,808	327,643	320,084	315,489	313,979	304,211	302,455	303,468	264,240	263,056	248,504	242,344	241,764	232,310	224,894	218,749	208,973	188,245	172,481	152,701
Intangible assets, net
708,100	712,900	727,700	742,400	757,100	761,600	107,861	111,773	115,685	119,600	29,202	30,756	32,311	33,865	35,419	52,645	55,010	40,758	59,738	62,110	56,202	58,344	64,464	66,678	68,928	30,148	30,771	-	-	0	0	0	0	11,765	12,065	12,548	12,741
In-process research and development
29,000	29,000	41,000	41,000	41,000	50,000	-	-	-	0	-	-	-	-	0	41,800	42,501	701	42,501	52,328	77,800	60,628	50,300	50,300	50,300	41,800	41,800	41,800	41,800	41,800	41,800	41,800	41,800	51,400	51,400	51,400	51,400
Goodwill
266,400	266,600	268,600	268,300	267,700	259,700	49,130	49,130	49,130	49,100	41,001	41,001	41,001	41,001	41,001	54,902	54,902	41,001	52,585	52,585	41,984	52,585	41,301	47,188	47,188	13,954	14,294	5,502	5,502	5,502	5,502	5,502	5,502	5,502	5,502	5,029	5,029
Deferred tax assets, net
17,600	13,400	-	-	-	13,400	12,652	12,654	12,656	2,800	4,864	5,022	5,022	6,096	11,286	18,192	11,124	11,286	13,747	13,481	12,863	12,764	17,043	16,411	1,203	0	11,087	11,087	11,087	11,087	6,728	11,016	8,349	13,999	18,278	27,970	33,757
Income tax receivable, long-term
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15,596	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
81,800	76,900	67,400	56,400	46,000	13,700	5,757	4,869	3,078	6,100	6,644	3,723	3,037	2,483	1,781	1,846	2,117	2,155	6,844	7,247	7,696	8,216	8,340	8,768	9,365	3,373	441	562	573	730	750	713	745	807	707	712	1,198
Non-current assets of discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	76,365	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total assets
2,278,700	2,327,300	2,333,800	2,321,300	2,153,700	2,229,400	1,173,623	1,138,891	1,068,467	1,070,200	1,024,202	970,483	951,639	970,111	932,026	1,056,466	1,035,897	1,037,484	976,548	943,323	917,845	938,691	869,291	837,249	823,251	626,630	595,464	555,614	538,385	564,230	540,025	527,140	514,687	546,864	512,962	493,984	500,319
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
84,200	94,800	91,300	124,500	78,600	80,700	38,874	41,629	46,216	41,800	30,111	29,604	27,179	34,649	46,342	58,974	45,611	37,970	41,248	41,824	40,583	40,930	39,351	36,968	36,643	27,521	29,018	25,711	23,871	31,297	27,348	23,301	28,316	40,530	33,902	32,182	25,409
Accrued expenses
41,500	39,500	51,800	54,800	49,600	30,700	7,425	10,552	6,840	4,800	3,918	1,874	4,346	6,368	4,279	2,482	4,187	6,207	4,214	6,442	4,606	6,274	4,688	2,957	4,879	1,252	1,359	1,067	1,517	1,488	1,332	1,623	1,134	1,170	1,150	1,200	1,309
Debt, current portion
47,500	62,400	55,800	44,700	36,900	58,200	41,807	29,259	24,513	37,900	32,626	24,326	23,318	34,537	32,102	29,778	26,528	31,998	30,089	26,320	20,818	31,654	26,850	23,044	18,242	24,615	18,421	15,481	11,675	22,726	16,170	13,980	9,982	20,884	14,735	13,823	23,975
Debt, current portion
26,300	12,900	-	-	-	10,100	-	-	-	0	0	0	0	20,000	20,000	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contingent consideration, current portion
-	-	55,700	54,600	62,700	5,600	2,954	2,852	2,337	2,400	2,393	1,710	2,216	3,266	2,759	2,983	2,580	2,109	2,490	3,040	6,860	6,487	2,488	3,813	3,193	1,341	1,326	-	-	0	0	0	0	1,748	9,865	9,734	0
Provision for chargebacks
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2,512	1,960	-	1,950	1,993	2,164	2,246	2,139	4,224	4,099	0	-	-	-	-	-	-	-	-	-	-	-
Income taxes payable, net
-	-	-	-	-	-	164	2,771	-	0	1,875	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	115	-	-	-	0	-	-	-
Contract liability, current
-	-	-	-	-	-	10,790	9,750	6,964	13,200	4,509	15,412	10,647	7,036	4,824	7,129	9,589	3,979	8,734	7,343	5,266	5,345	5,813	5,333	5,180	1,834	2,038	2,049	2,008	1,811	1,574	1,504	283	1,362	4,359	5,336	7,839
Deferred tax liability, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	88	88	88	88	-	-	-	0	-	-	-	-	-	-	-
Long-term Debt, Current Maturities
-	-	10,100	10,100	10,100	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,470	4,470	4,470	4,470	4,148	4,057	3,280	5,360	4,920	10,229	17,187
Other current liabilities
7,600	6,700	10,600	12,500	10,500	15,100	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current liabilities of discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	17,348	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total current liabilities
207,100	216,300	275,300	301,200	248,400	200,400	102,014	96,813	86,870	100,100	75,432	72,926	67,706	105,856	110,306	103,858	90,455	99,611	88,725	86,962	80,297	92,936	81,417	76,427	72,324	56,651	56,632	48,778	43,541	61,907	50,572	44,465	42,995	71,054	68,931	72,504	75,719
Contingent consideration, net of current portion
26,100	26,000	14,500	10,400	10,000	54,400	9,003	9,839	10,133	9,900	9,398	9,503	9,601	9,919	20,169	22,580	23,114	23,046	22,271	33,795	41,594	34,599	16,745	19,193	19,127	15,278	15,255	-	-	0	0	0	0	3,005	5,992	6,206	14,532
Long-term Debt, Excluding Current Maturities
762,900	798,400	813,300	830,400	732,400	784,500	13,495	13,482	13,469	13,500	248,994	248,693	248,394	248,094	247,793	247,393	247,192	246,892	253,000	253,000	251,000	251,000	251,000	251,000	251,000	62,000	54,952	56,069	57,187	58,304	58,866	58,140	57,592	54,094	48,873	29,074	30,239
Deferred tax liability
63,900	63,900	61,100	65,600	66,400	67,500	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes payable
-	-	-	-	-	-	12,500	12,500	12,500	12,500	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contract liabilities, net of current portion
85,000	85,600	81,600	77,000	64,700	62,500	65,343	63,255	59,365	17,300	24,966	17,092	13,887	8,433	4,695	8,410	6,817	3,426	5,987	6,083	5,806	5,713	5,815	1,632	1,805	0	-	-	-	-	-	-	-	-	2,781	2,953	4,386
Deferred tax liability, net of current portion
-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	1,419	-	-	-	0	-	-	-	-	-	-	-
Other liabilities
58,900	48,600	53,000	47,800	44,300	49,200	4,619	4,656	4,850	4,600	1,702	1,670	1,632	1,604	1,440	1,553	1,337	1,258	1,253	1,232	1,270	1,242	1,176	1,230	1,500	2,117	1,768	1,685	1,852	1,891	2,175	2,013	2,005	1,984	1,882	2,017	1,882
Non-current liabilities of discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	3,234	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total liabilities
1,203,900	1,238,800	1,298,800	1,332,400	1,166,200	1,218,500	206,974	200,545	187,187	157,900	360,492	349,884	341,220	373,906	384,403	383,794	368,915	377,467	371,236	381,072	379,967	385,490	356,153	349,482	345,756	137,465	128,607	106,532	102,580	122,102	111,613	104,618	102,592	130,137	128,459	112,754	126,758
Commitments and contingencies (Notes 8 & 16)
-	-	-	-	-	-	-	-	0	-	0	0	0	0	0	-	-	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	-	0	0	0	-
Stockholders' equity:
Preferred stock, $0.001 par value; 15.0 shares authorized, no shares issued or outstanding
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock, $0.001 par value; 200.0 shares authorized, 53.5 and 53.0 shares issued; 52.3 and 51.7 shares outstanding, respectively
100	100	100	100	100	100	51	51	50	100	41	41	41	41	41	41	40	40	39	39	38	38	38	38	38	37	37	36	36	36	36	36	36	36	36	36	35
Treasury stock, at cost, 1.2 common shares
39,600	39,600	39,700	39,700	39,600	39,600	39,642	39,642	39,642	39,500	6,503	6,503	6,501	6,420	6,420	6,420	6,420	6,420	6,320	6,320	6,320	6,320	6,119	6,119	6,119	6,119	5,906	5,906	5,906	5,906	1,457	-	-	0	-	-	-
Additional paid-in capital
726,200	716,100	708,800	701,800	690,200	688,600	640,178	632,569	624,484	618,300	370,855	360,999	355,661	352,435	342,888	337,947	322,384	317,971	297,953	291,339	280,653	274,222	264,877	260,778	255,675	247,637	240,372	236,099	232,887	230,964	228,080	225,231	222,746	220,654	215,938	213,320	197,689
Accumulated other comprehensive loss, net
-21,200	-9,900	-9,100	-5,000	-4,500	-5,500	-4,666	-4,415	-3,251	-3,700	-3,815	-3,519	-3,747	-4,331	-3,572	-3,080	-4,152	-2,713	-4,152	-3,657	-3,242	-3,008	-3,810	-3,251	-3,391	-3,465	-3,502	-3,513	-3,759	-4,129	-3,901	-3,249	-3,229	-3,313	-2,894	-2,771	-2,110
Retained earnings
409,300	421,800	374,900	331,700	341,300	367,300	370,728	349,783	299,639	337,100	303,132	269,581	264,965	254,480	214,686	344,184	355,130	351,139	317,792	280,850	266,749	288,269	258,152	236,321	231,292	251,528	236,305	222,814	212,330	220,393	204,286	197,670	190,041	196,869	168,212	166,663	173,850
Total stockholders' equity
1,074,800	1,088,500	1,035,000	988,900	-	1,010,900	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	513,138	487,767	477,495	489,618	467,306	449,530	435,588	441,358	427,044	419,688	409,594	414,246	381,292	377,248	369,464
Noncontrolling interest in subsidiaries
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-453	-449	-448	217	770	1,368	2,834	2,501	2,481	3,211	3,982	4,097
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
-	-	-	-	987,500	-	966,649	938,346	881,280	912,300	663,710	620,599	610,419	596,205	547,623	672,672	666,982	660,017	605,312	562,251	537,878	553,201	513,138	487,767	477,495	489,165	466,857	449,082	435,805	442,128	428,412	422,522	412,095	416,727	384,503	381,230	373,561
Total liabilities and stockholders' equity
2,278,700	2,327,300	2,333,800	2,321,300	2,153,700	2,229,400	1,173,623	1,138,891	1,068,467	1,070,200	1,024,202	970,483	951,639	970,111	932,026	1,056,466	1,035,897	1,037,484	976,548	943,323	917,845	938,691	869,291	837,249	823,251	626,630	595,464	555,614	538,385	564,230	540,025	527,140	514,687	546,864	512,962	493,984	500,319